Positive Effect of Methylphenidate for Cancer-Related Cognitive Impairment: A Pilot Randomized Trial.
Journal of pain and symptom management · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMethylphenidateFemalePilot ProjectsDouble-Blind MethodBreast NeoplasmsMiddle AgedTreatment OutcomeCentral Nervous System StimulantsNeuropsychological TestsCognitive EnhancementAdultChemotherapy-Related Cognitive ImpairmentFeasibility StudiesCognition DisordersCancer-related cognitive impairmentbreast cancercognitive dysfunctionmethylphenidaterandomized controlled trial
Come citare questo studio
Jessica Boivin, Anne Dagnault, Maman Joyce Dogba, Vicky Tessier, Pierre R Gagnon, Aida Eslami, Christophe Grenier, Bruno Gagnon. (2026). Positive Effect of Methylphenidate for Cancer-Related Cognitive Impairment: A Pilot Randomized Trial.. Journal of pain and symptom management. DOI: 10.1016/j.jpainsymman.2026.08.010
Consulta la pubblicazione originale ↗